I just wish they would stop shifting timelines then failing to make the new ones multiple times. The stroke study is the worst. This has been pushed back many times already then as recently as the last quarterly at the end of April they announced there was a further slight delay until mid Q2 this year. That is now in the rear view mirror. It would not shock me in the least to find out they ran this trial already and got poor results so are trying to repeat it before making any announcements. This is pure speculation on my part but makes more sense to me than having no idea when you're study will actually finish. Now if the announce stellar results in the next week or so then I'll shut my mouth.
NYR Price at posting:
8.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)